Kiran Musunuru, M.D., Ph.D.
This page shows the publications Kiran Musunuru has written about Point Mutation.
Musunuru K. Genome editing of a CArG element in the mouse genome establishes its role in gene expression. Arterioscler Thromb Vasc Biol. 2015 Mar; 35(3):496-7.
Musunuru K. Correcting tyrosinaemia via a point mutation. Nat Biomed Eng. 2020 01; 4(1):14-15.
Musunuru K, Hillard VH, Murali R. Widespread central nervous system cavernous malformations associated with café-au-lait skin lesions. Case report. J Neurosurg. 2003 Aug; 99(2):412-5.
Jensen KB, Musunuru K, Lewis HA, Burley SK, Darnell RB. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc Natl Acad Sci U S A. 2000 May 23; 97(11):5740-5.
Lewis HA, Chen H, Edo C, Buckanovich RJ, Yang YY, Musunuru K, Zhong R, Darnell RB, Burley SK. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Structure. 1999 Feb 15; 7(2):191-203.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.